Publications by authors named "Regis Coutant"

Article Synopsis
  • Osteoporosis is a skeletal disorder leading to increased fracture risk, and when it affects young individuals, it often indicates genetic causes related to early-onset osteoporosis (EOOP).
  • Over 577 patients with primary osteoporosis were studied using next-generation sequencing of 21 bone fragility-related genes, revealing that around 18% had a genetic basis, primarily linked to the LRP5 gene.
  • A rare finding included 17 patients with a variant in the PLS3 gene, suggesting the involvement of dominant X-linked osteoporosis, predominantly affecting males, but also identified severe cases in females, pointing toward possible genetic interactions.
View Article and Find Full Text PDF
Article Synopsis
  • Around 10,000 children in France with growth hormone deficiency are treated daily with recombinant human growth hormone, which effectively helps with growth but poses adherence challenges.
  • Daily injections can negatively impact the quality of life for patients and their families, prompting interest in long-acting growth hormones (LAGH) that require less frequent administration.
  • New LAGHs, like somatrogon MA, are now available in Europe, but there are ongoing questions about their effectiveness and safety, highlighting the need for further studies and practical guidelines for doctors.
View Article and Find Full Text PDF
Article Synopsis
  • * The French Endocrine Society and associated organizations created a reference document to address the complexities of managing these tumors, which can recur and lead to serious health issues, including impaired quality of life for patients, especially those with hypothalamic syndrome.
  • * Recent research has identified two tumor types—papillary and adamantinomatous—with different molecular signatures and treatment strategies, prompting ongoing developments in therapeutic options, including new medications for associated symptoms like hyperphagia.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the long-term effects of using a hybrid closed loop (HCL) system on glucose levels and body mass index (BMI) in children with type 1 diabetes during puberty.* -
  • Over 30 months, data showed that improvements in HbA1c levels were maintained and BMI scores remained stable in participants, with no severe hypoglycemic events and only one unrelated ketoacidosis case.* -
  • Findings suggest that prolonged HCL usage can help manage glucose control during puberty without negatively affecting BMI in children with type 1 diabetes.*
View Article and Find Full Text PDF

Purpose: The purpose of this study was to characterize the phenotype associated with a de novo gain-of-function variant in the GUCY1A2 gene.

Methods: An individual carrying the de novo heterozygous variant c.1458G>T p.

View Article and Find Full Text PDF

Hypopituitarism (or pituitary deficiency) is a rare disease with an estimated prevalence of between 1/16,000 and 1/26,000 individuals, defined by insufficient production of one or several anterior pituitary hormones (growth hormone [GH], thyroid-stimulating hormone [TSH], adrenocorticotropic hormone [ACTH], luteinizing hormone [LH], follicle-stimulating hormone [FSH], prolactin), in association or not with diabetes insipidus (antidiuretic hormone [ADH] deficiency). While in adults hypopituitarism is mostly an acquired disease (tumors, irradiation), in children it is most often a congenital condition, due to abnormal pituitary development. Clinical symptoms vary considerably from isolated to combined deficiencies and between syndromic and non-syndromic forms.

View Article and Find Full Text PDF

Context: The increase in bone mineral content (BMC) and density (BMD) measured by dual-energy x-ray absorptiometry (DXA) in obese children may not sustain the mechanical load associated with weight, and the factors influencing bone mineralization are not well known.

Objective: We described bone mineralization in boys with overweight/obesity and leanness in relation to body composition.

Methods: Cross-sectional study in the Pediatric Endocrinology Unit of Angers University Hospital with 249 overweight/obese boys aged 8-18 who underwent DXA and insulin, testosterone, and IGF-1 measurements.

View Article and Find Full Text PDF
Article Synopsis
  • - This study aimed to analyze the final height (FH) trends in French patients with X-linked hypophosphatemia (XLH) over the past decades, as there was limited data on FH's natural history in this condition.
  • - Researchers conducted a retrospective study involving 398 XLH patients, dividing them into three birth groups (1950-1974, 1975-2000, and 2001-2006) to compare their average final heights.
  • - Results showed a significant increase in mean FH over the generations, with men still being shorter than women, indicating ongoing challenges in treating XLH. Despite improvements, many patients continue to have short stature, highlighting the need for continued progress.
View Article and Find Full Text PDF

Osteogenesis imperfecta (OI) and hypophosphatasia (HPP) are rare skeletal disorders caused by mutations in the genes encoding collagen type I (COL1A, COL1A2) and tissue-non-specific isoenzyme of alkaline phosphatase (ALPL), respectively. Both conditions result in skeletal deformities and bone fragility although bone tissue abnormalities differ considerably. Children with OI have low bone mass and hypermineralized matrix, whereas HPP children develop rickets and osteomalacia.

View Article and Find Full Text PDF
Article Synopsis
  • * The condition is characterized by specific symptoms related to a pituitary tumor, such as headaches and joint pain, and can lead to various complications including cardiovascular and metabolic issues.
  • * Diagnosis involves elevated IGF-I levels and imaging to identify the pituitary tumor; treatment typically starts with surgery, but medication and radiation may be necessary for some patients, and care is best administered by a specialized multidisciplinary team.
View Article and Find Full Text PDF

Unlabelled: Childhood obesity is associated with many comorbidities. Bariatric surgery is known to be efficient for reducing weight in adolescents.

Objectives: The primary outcome was to identify somatic or psychosocial factors associated with success at 24 months after a laparoscopic adjustable gastric banding (LAGB) procedure in our cohort of adolescents with severe obesity.

View Article and Find Full Text PDF
Article Synopsis
  • Growth hormone (GH) therapy significantly improves height outcomes in children born small for gestational age (SGA), with a study tracking 291 children over 5 years showing that 66.3% achieved normal height standards.
  • Key factors influencing the success of GH treatment included the child's initial height, age at the start of treatment, overall duration of treatment, and absence of chronic diseases.
  • The study found that most adverse events were non-serious, indicating that while GH therapy was generally effective, it didn't present new safety issues.
View Article and Find Full Text PDF
Article Synopsis
  • * It analyzed data from 60 children over four treatment phases, noting the percentage of time their glucose levels stayed in the target range while considering missed boluses.
  • * Results indicate that HCL therapy consistently improved glycemic control compared to SAP, even when meal insulin was missed, suggesting HCL may be the better choice for managing diabetes in children.
View Article and Find Full Text PDF

Introduction: Congenital hypothyroidism with gland-in-situ (CH-GIS) is usually attributed to mutations in the genes involved in thyroid hormone production. The diagnostic yield of targeted next-generation sequencing (NGS) varied widely between studies. We hypothesized that the molecular yield of targeted NGS would depend on the severity of CH.

View Article and Find Full Text PDF

Objective: The objective of this study was to describe in a real-life setting the treatment burden and adherence and quality of life (QOL) of children treated with daily injections of growth hormone and their relationship with treatment duration.

Design: This non-interventional, multicenter, cross-sectional French study involved children aged 3-17 years treated with daily growth hormone injections.

Methods: Based on a recent validated dyad questionnaire, the mean overall life interference total score (100 = most interference) was described, with treatment adherence and QOL, using the Quality of Life of Short Stature Youth questionnaire (100 = best).

View Article and Find Full Text PDF

Zinc is an essential trace mineral. Dietary zinc deficiency results in stunted growth, skin lesions, hypogonadism and frequent infections in humans. Mice genetically lacking Slc30a7 suffer from mild zinc deficiency and are prone to development of prostate cancer and insulin resistance.

View Article and Find Full Text PDF

Silver-Russell syndrome (SRS) is a rare imprinting disorder characterized by prenatal and postnatal growth retardation. The two principal causes of SRS are loss of methylation on chromosome 11p15 (11p15 LOM) and maternal uniparental disomy of chromosome 7 (UPD(7)mat). Knowledge of the neuropsychological profile of SRS remains sparse and incomplete even if several difficulties related to attention and learning have been reported both in the literature and by patients with SRS.

View Article and Find Full Text PDF
Article Synopsis
  • X-linked hypophosphatemia (XLH) leads to issues like increased FGF23, low phosphate levels, and growth problems, but treatments like vitamin D supplements, phosphate, and rhGH are used to improve outcomes.
  • A study involving 36 patients showed limited height improvements in those treated with burosumab alone, while those on combined rhGH and burosumab therapies experienced continued height gains.
  • The research is significant as it’s one of the largest in Europe, indicating that combining rhGH with burosumab appears safe and may enhance growth in children with XLH.
View Article and Find Full Text PDF
Article Synopsis
  • Gonadectomy is advised for patients with Turner syndrome (TS) and 45,X/46,XY karyotype due to the risk of gonadoblastoma (GB), but the evidence supporting this recommendation is weak.
  • This study aimed to analyze the prevalence and characteristics of GB linked to different types of Y chromosomal material in affected patients.
  • Findings revealed a 12.8% prevalence of GB among 70 patients studied, with complete Y chromosome presence identified as a significant risk factor, suggesting the need for earlier gonadectomy in these cases.*
View Article and Find Full Text PDF

The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - Turner syndrome (TS) is a rare genetic condition affecting about 1 in 2,500 liveborn girls, characterized by the absence of all or part of an X chromosome, with common karyotypes being 45,X and 45,X/46,XX mosaic.
  • - The French National Diagnosis and Care Protocol (PNDS) aims to guide healthcare professionals in managing TS, providing insights based on expert consensus and literature review from the French National Reference Center for Rare Growth and Developmental Endocrine disorders.
  • - TS can lead to several health issues, including growth retardation, gonadal dysgenesis, and increased risk of various congenital and acquired diseases, necessitating a collaborative approach among healthcare providers for effective patient
View Article and Find Full Text PDF

Context: Resistance to thyroid hormone β syndrome (RTHβ) is caused by pathogenic variants in the THRB gene, but such variants are found in only 85% of cases. We report the case of a patient with RTHβ phenotype but for whom we found a pathogenic variant of the THRB gene in a mosaic state.

Case Description: The patient is a 52-year-old woman with clinical and biological signs of RTHβ.

View Article and Find Full Text PDF

Growth hormone (GH) has been used for over 35 years, and its safety and efficacy has been studied extensively. Experimental studies showing the permissive role of GH/insulin-like growth factor 1 (IGF-I) in carcinogenesis have raised concerns regarding the safety of GH replacement in children and adults who have received treatment for cancer and those with intracranial and pituitary tumours. A consensus statement was produced to guide decision-making on GH replacement in children and adult survivors of cancer, in those treated for intracranial and pituitary tumours and in patients with increased cancer risk.

View Article and Find Full Text PDF

Silver-Russell syndrome (SRS) is a rare imprinting disorder characterized by prenatal and postnatal growth retardation. Despite normal intellectual functioning, psychosocial and behavioral difficulties have been observed in this syndrome. However, few studies have dealt with these aspects, even though this could enhance the current understanding of the SRS and, more importantly, improve the management of potential psychosocial problems.

View Article and Find Full Text PDF

Cushing's syndrome is defined by prolonged exposure to glucocorticoids, leading to excess morbidity and mortality. Diagnosis of this rare pathology is difficult due to the low specificity of the clinical signs, the variable severity of the clinical presentation, and the difficulties of interpretation associated with the diagnostic methods. The present consensus paper by 38 experts of the French Society of Endocrinology and the French Society of Pediatric Endocrinology and Diabetology aimed firstly to detail the circumstances suggesting diagnosis and the biologic diagnosis tools and their interpretation for positive diagnosis and for etiologic diagnosis according to ACTH-independent and -dependent mechanisms.

View Article and Find Full Text PDF